-
Geographic distribution of clinical trials may lead to inequities in access
Elizabeth M Seidler, Aparna Keshaviah, Case Brown, Elizabeth Wood, Lisa Granick & Alexandra B Kimball
Research Article: Clinical Investigation
-
Geographic distribution of clinical trials may lead to inequities in access
Elizabeth M Seidler, Aparna Keshaviah, Case Brown, Elizabeth Wood, Lisa Granick & Alexandra B Kimball
Research Article: Clinical Investigation
-
Geographic distribution of clinical trials may lead to inequities in access
Elizabeth M Seidler, Aparna Keshaviah, Case Brown, Elizabeth Wood, Lisa Granick & Alexandra B Kimball
Research Article: Clinical Investigation
-
Geographic distribution of clinical trials may lead to inequities in access
Elizabeth M Seidler, Aparna Keshaviah, Case Brown, Elizabeth Wood, Lisa Granick & Alexandra B Kimball
Research Article: Clinical Investigation
-
Geographic distribution of clinical trials may lead to inequities in access
Elizabeth M Seidler, Aparna Keshaviah, Case Brown, Elizabeth Wood, Lisa Granick & Alexandra B Kimball
Research Article: Clinical Investigation
-
Geographic distribution of clinical trials may lead to inequities in access
Elizabeth M Seidler, Aparna Keshaviah, Case Brown, Elizabeth Wood, Lisa Granick & Alexandra B Kimball
Research Article: Clinical Investigation
-
Geographic distribution of clinical trials may lead to inequities in access
Elizabeth M Seidler, Aparna Keshaviah, Case Brown, Elizabeth Wood, Lisa Granick & Alexandra B Kimball
Research Article: Clinical Investigation
-
Geographic distribution of clinical trials may lead to inequities in access
Elizabeth M Seidler, Aparna Keshaviah, Case Brown, Elizabeth Wood, Lisa Granick & Alexandra B Kimball
Research Article: Clinical Investigation
-
The UK Dermatology Clinical Trials Network: how far have we come?
Carron Layfield, Adrian Yong, Kim Thomas and Hywel Williams
Research Update: Clinical Investigation
-
The UK Dermatology Clinical Trials Network: how far have we come?
Carron Layfield, Adrian Yong, Kim Thomas and Hywel Williams
Research Update: Clinical Investigation
-
The UK Dermatology Clinical Trials Network: how far have we come?
Carron Layfield, Adrian Yong, Kim Thomas and Hywel Williams
Research Update: Clinical Investigation
-
The UK Dermatology Clinical Trials Network: how far have we come?
Carron Layfield, Adrian Yong, Kim Thomas and Hywel Williams
Research Update: Clinical Investigation
-
The UK Dermatology Clinical Trials Network: how far have we come?
Carron Layfield, Adrian Yong, Kim Thomas and Hywel Williams
Research Update: Clinical Investigation
-
The UK Dermatology Clinical Trials Network: how far have we come?
Carron Layfield, Adrian Yong, Kim Thomas and Hywel Williams
Research Update: Clinical Investigation
-
The UK Dermatology Clinical Trials Network: how far have we come?
Carron Layfield, Adrian Yong, Kim Thomas and Hywel Williams
Research Update: Clinical Investigation
-
The UK Dermatology Clinical Trials Network: how far have we come?
Carron Layfield, Adrian Yong, Kim Thomas and Hywel Williams
Research Update: Clinical Investigation
-
The challenges of pregnancy in clinical trials for vaccines
Flor M Munoz
Editorial: Clinical Investigation
-
The challenges of pregnancy in clinical trials for vaccines
Flor M Munoz
Editorial: Clinical Investigation
-
The challenges of pregnancy in clinical trials for vaccines
Flor M Munoz
Editorial: Clinical Investigation
-
The challenges of pregnancy in clinical trials for vaccines
Flor M Munoz
Editorial: Clinical Investigation
-
The challenges of pregnancy in clinical trials for vaccines
Flor M Munoz
Editorial: Clinical Investigation
-
The challenges of pregnancy in clinical trials for vaccines
Flor M Munoz
Editorial: Clinical Investigation
-
The challenges of pregnancy in clinical trials for vaccines
Flor M Munoz
Editorial: Clinical Investigation
-
The challenges of pregnancy in clinical trials for vaccines
Flor M Munoz
Editorial: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immunosuppression and renal transplant rejection: review of current and emerging therapies
Roberto Marcen
Review Article: Clinical Investigation
-
Immunosuppression and renal transplant rejection: review of current and emerging therapies
Roberto Marcen
Review Article: Clinical Investigation
-
Immunosuppression and renal transplant rejection: review of current and emerging therapies
Roberto Marcen
Review Article: Clinical Investigation
-
Immunosuppression and renal transplant rejection: review of current and emerging therapies
Roberto Marcen
Review Article: Clinical Investigation
-
Immunosuppression and renal transplant rejection: review of current and emerging therapies
Roberto Marcen
Review Article: Clinical Investigation
-
Immunosuppression and renal transplant rejection: review of current and emerging therapies
Roberto Marcen
Review Article: Clinical Investigation
-
Immunosuppression and renal transplant rejection: review of current and emerging therapies
Roberto Marcen
Review Article: Clinical Investigation
-
Immunosuppression and renal transplant rejection: review of current and emerging therapies
Roberto Marcen
Review Article: Clinical Investigation